{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:13:18Z","timestamp":1778541198802,"version":"3.51.4"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Previous research has shown a tight relationship between the G0\/G1 switch gene 2 (G0S2) and metabolic diseases such as non-alcoholic fatty liver disease (NAFLD) and obesity and diabetes, and insulin resistance has been shown as the major risk factor for both NAFLD and T2DM. However, the mechanisms underlying the relationship between G0S2 and insulin resistance remain incompletely understood. Our study aimed to confirm the effect of G0S2 on insulin resistance, and determine whether the insulin resistance in mice fed a high-fat diet (HFD) results from G0S2 elevation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we extracted livers from mice that consumed HFD and received tail vein injections of AD-G0S2\/Ad-LacZ, and performed a proteomics analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Proteomic analysis revealed that there was a total of 125 differentially expressed proteins (DEPs) (56 increased and 69 decreased proteins) among the identified 3583 proteins. Functional enrichment analysis revealed that four insulin signaling pathway-associated proteins were significantly upregulated and five insulin signaling pathway -associated proteins were significantly downregulated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings show that the DEPs, which were associated with insulin resistance, are generally consistent with enhanced insulin resistance in G0S2 overexpression mice. Collectively, this study demonstrates that G0S2 may be a potential target gene for the treatment of obesity, NAFLD, and diabetes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1130350","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T06:41:04Z","timestamp":1679553664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of G0S2 on insulin sensitivity: A proteomic analysis in a G0S2-overexpressed high-fat diet mouse model"],"prefix":"10.3389","volume":"14","author":[{"given":"Dongming","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengzhe","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet","article-title":"CD24-siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00407-5","article-title":"Therapeutic RNA-silencing oligonucleotides in metabolic diseases","volume":"21","author":"Goga","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell","article-title":"Mechanisms for insulin resistance: Common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318547111","article-title":"Evaluation of intramitochondrial ATP levels identifies G0\/G1 switch gene 2 as a positive regulator of oxidative phosphorylation","volume":"111","author":"Kioka","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2017.06.007","article-title":"G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux","volume":"1862","author":"Zhang","year":"2017","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e38280","DOI":"10.1371\/journal.pone.0038280","article-title":"The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells","volume":"7","author":"Ivanovic","year":"2012","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00551-9","article-title":"Autophagy in metabolic disease and ageing","volume":"17","author":"Kitada","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"B11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus \u2014 mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2019.06.015","article-title":"Activation of G0\/G1 switch gene 2 by endoplasmic reticulum stress enhances hepatic steatosis","volume":"99","author":"Ma","year":"2019","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3429-z","article-title":"Deletion of the gene encoding G0\/G1 switch protein 2 (G0s2) alleviates high-fat-diet-induced weight gain and insulin resistance, and promotes browning of white adipose tissue in mice","volume":"58","author":"El-Assaad","year":"2015","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.786525","article-title":"Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice","volume":"292","author":"Irimia","year":"2017","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13185","article-title":"Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes","volume":"36","author":"Valenti","year":"2016","journal-title":"Liver Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/jci200523621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.021","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e88735","DOI":"10.1172\/jci.insight.88735","article-title":"Liver X receptor \u03b1 mediates hepatic triglyceride accumulation through upregulation of G0\/G1 switch gene 2 expression","volume":"2","author":"Heckmann","year":"2017","journal-title":"JCI Insight"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.035","article-title":"Fasting-induced G0\/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids","volume":"63","author":"Jaeger","year":"2015","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj","article-title":"Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet","volume":"60","author":"Nojima","year":"2012","journal-title":"Endocr J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12864-021-08211-y","article-title":"The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model","volume":"22","author":"Wu","year":"2021","journal-title":"BMC Genomics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/pr3000927","article-title":"Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and wnt-5a as novel constituents of fibrotic liver","volume":"11","author":"Rashid","year":"2012","journal-title":"J Proteome Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200700189","article-title":"Label-free LC-MS\/MS quantitative proteomics for large-scale biomarker discovery in complex samples","volume":"30","author":"Levin","year":"2007","journal-title":"J Separation Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/ac050846r","article-title":"Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling","volume":"77","author":"Zybailov","year":"2005","journal-title":"Anal Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/pr401169d","article-title":"Functional annotation of proteome encoded by human chromosome 22","volume":"13","author":"Pinto","year":"2014","journal-title":"J Proteome Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00859","article-title":"A novel truncated form of nephronectin is present in small extracellular vesicles isolated from 66cl4 cells","volume":"18","author":"Toraskar","year":"2019","journal-title":"J Proteome Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn176","article-title":"High-throughput functional annotation and data mining with the Blast2GO suite","volume":"36","author":"Gotz","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.12.070","article-title":"Label-free quantitative proteomic analysis of the biological functions of moringa oleifera seed proteins provides insights regarding the milk-clotting proteases","volume":"144","author":"Wang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.663019","article-title":"Pathological features of enterovirus 71-associated brain and lung damage in mice based on quantitative proteomic analysis","volume":"12","author":"Jin","year":"2021","journal-title":"Front Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.05.006","article-title":"Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db18-0638","article-title":"Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1","volume":"68","author":"Yan","year":"2019","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1422","article-title":"Targeted disruption of G0\/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet\u2013 induced liver steatosis","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025944723047","article-title":"\u03b2-catenin and tcfs in mammary development and cancer","volume":"8","author":"Hatsell","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2008.10.012","article-title":"Chanarin\u2013dorfman syndrome: Deficiency in CGI-58, a lipid droplet-bound coactivator of lipase","volume":"1791","author":"Yamaguchi","year":"2009","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in chanarin-dorfman syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00125-018-4785-x","article-title":"Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis","volume":"62","author":"Voss","year":"2018","journal-title":"Diabetologia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-022-04577-3","article-title":"Methyl-CpG-binding domain protein 2 contributes to renal fibrosis through promoting polarized M1 macrophages","volume":"13","author":"Ai","year":"2022","journal-title":"Cell Death Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4286047","article-title":"The expression pattern and regulatory mechanism of the G0\/G1 switch gene 2 (G0S2) in the pathogenesis and treatment ofAChR myasthenia gravis (MG)","volume":"2020","author":"Xu","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1159","article-title":"Reduced mRNA and protein expression of perilipin a and G0\/G1 switch gene 2 (G0S2) in human adipose tissue in poorly controlled type 2 diabetes","volume":"97","author":"Nielsen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30937","article-title":"Vitamin d receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.157","article-title":"The role of FOXO1 in \u03b2-cell failure and type 2 diabetes mellitus","volume":"9","author":"Kitamura","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.030","article-title":"The regulation of FOXO1 and its role in disease progression","volume":"193","author":"Xing","year":"2018","journal-title":"Life Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"35531","DOI":"10.1038\/srep35531","article-title":"LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00302.2003","article-title":"Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle","volume":"286","author":"Steinberg","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0508-9","article-title":"Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects","volume":"50","author":"Ghanim","year":"2006","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0979","article-title":"Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal","volume":"32","author":"Ghanim","year":"2009","journal-title":"Diabetes Care"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2665-3","article-title":"Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance","volume":"55","author":"Palanivel","year":"2012","journal-title":"Diabetologia"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210689200","article-title":"Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes","volume":"278","author":"Senn","year":"2003","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.3390\/nu12123612","article-title":"POCU1b, the n-butanol soluble fraction of polygoni cuspidati rhizoma et radix, attenuates obesity, non-alcoholic fatty liver, and insulin resistance via inhibitions of pancreatic lipase, cAMP-dependent PDE activity, AMPK activation, and SOCS-3 suppression","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2010.08.013","article-title":"In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis","volume":"20","author":"Stuible","year":"2010","journal-title":"Trends Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.1134966","article-title":"Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B","volume":"315","author":"Yudushkin","year":"2007","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"12693","DOI":"10.3390\/ijms222312693","article-title":"A novel PTP1B inhibitor-phosphate of polymannuronic acid ameliorates insulin resistance by regulating IRS-1\/Akt signaling","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.016","article-title":"MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis","volume":"66","author":"Wu","year":"2017","journal-title":"J Hepatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29690","article-title":"Long intergenic noncoding RNA 00844 promotes apoptosis and represses proliferation of prostate cancer cells through upregulating GSTP1 by recruiting EBF1","volume":"235","author":"Qiu","year":"2020","journal-title":"J Cell Physiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-020-00979-y","article-title":"Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma","volume":"13","author":"Lei","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-021-02978-0","article-title":"GSTP1 as a novel target in radiation induced lung injury","volume":"19","author":"Lei","year":"2021","journal-title":"J Trans Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209576","article-title":"Human glutathione s-transferase P1-1 interacts with TRAF2 and regulates TRAF2\u2013ASK1 signals","volume":"25","author":"Wu","year":"2006","journal-title":"Oncogene"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1104406","article-title":"GSTM1, GSTT1, and GSTP1 polymorphisms and associations between air pollutants and markers of insulin resistance in elderly koreans","volume":"120","author":"Kim","year":"2012","journal-title":"Environ Health Perspect"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/jci88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.celrep.2018.07.063","article-title":"Peroxisome proliferator-activated receptor \u03b32 controls the rate of adipose tissue lipid storage and determines metabolic flexibility","volume":"24","author":"Virtue","year":"2018","journal-title":"Cell Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2020.08.016","article-title":"Obesity-linked PPARg S273 phosphorylation promotes insulin resistance through growth differentiation factor 3","volume":"32","author":"Hall","year":"2020","journal-title":"Cell Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.01.003","article-title":"Hepatocyte-specific loss of PPARg protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver","volume":"11","author":"Lee","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1130350\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T06:41:07Z","timestamp":1679553667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1130350\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":73,"alternative-id":["10.3389\/fendo.2023.1130350"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1130350","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"article-number":"1130350"}}